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The AP2a gene encodes a transcription factor containing a basic, helix–span–helix DNA-binding/dimerization domain,
which is developmentally regulated and retinoic acid inducible. Recent reports about AP2a null mice indicate that AP2a
plays an important role in embryogenesis, especially in craniofacial development and midline fusion. Ocular development
is also affected in these null mice. As AP2a may be involved in transcriptional regulation in the lens, it was important to
examine the expression of the AP2a gene in the lens. Four AP2a mRNA variants have been previously isolated from whole
mouse embryos. Variants 1, 3, and 4 are transcriptional activators that are transcribed from different promoters and variant
2 is a repressor lacking the activation domain encoded by exon 2. Using in situ-PCR, we found that AP2a is expressed in
the lens epithelia but not in the lens fibers. RT-PCR analysis of lens mRNA with amplimers specific for each variant
revealed that AP2a variants 1, 2, and 3 are expressed in newborn mouse lenses. However, variant 4 is not expressed in the
lens. In this report we characterized a novel isoform, which we named variant 5, expressed in the lens and kidney. Variant
5, which is generated by alternative splicing, may function as a repressor due to the partial deletion of the proline-rich
transactivation domain encoded by exon 2. This is the first molecular characterization of AP2a gene expression in the lens.
Our results indicate that two activator and two repressor AP2a isoforms may play a role in regulating gene expression in
the lens. © 1998 Academic Press
INTRODUCTION
Transcriptional regulation plays a central role in the cell
differentiation program during development. Tissue-
specific gene expression requires precise temporal and spa-
tial regulation during embryogenesis. To elucidate the
mechanisms involved in tissue-specific expression, many
transcription factors which interact with specific DNA
sequences have been characterized. Published data reveal
that not only tissue-specific factors but also general or
tissue-preferred factors including positive and negative
transcriptional regulators are involved in the precise regu-
lation of cell-type-restricted gene expression (Mendel and
Crabtree, 1991; Snape et al., 1991; Zhang et al., 1994; Ho et
al., 1996). Either many transcription factors belong to
protein families with conserved DNA-binding domains or
multiple isoforms lacking either the activation or the
DNA-binding domains arise from a single gene by alterna-
tive splicing, generating activators or repressors (Kingsley
and Winoto, 1992; Buettner et al., 1993; Grove and Plumb,
1993; Meier et al., 1995; Oyake et al., 1996; Skerjanc et al.,
1996). Their DNA and protein/protein interaction domains
function as modules, allowing modulation of their regula-
tory functions depending on their cellular environment.
The transcription factor AP2 is a retinoic acid-inducible
factor that was initially isolated from HeLa cells (Williams
et al., 1988; Luscher et al., 1989). The mouse and Xenopus
orthologous genes were subsequently characterized (Win-
ning et al., 1991; Moser et al., 1993). During mouse em-
bryogenesis, AP2 is expressed in neural crest cells and in
restricted parts of the nervous system, face, limbs, nephric
system, and epidermis (Mitchell et al., 1991). The expres-
sion pattern of AP2 during Xenopus development is similar
to the one in the mouse (Winning et al., 1991). AP2 is
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essential for epidermis-specific keratin gene expression in
human and Xenopus (Leask et al., 1991; Snape et al., 1991;
Winning et al., 1991; Byrne et al., 1994). Two recent reports
of AP2 null mutant mice indicate that AP2 plays a key role
in early embryogenesis, especially in cranial development.
The null mice fail to close the cranial neural tube and have
severe dismorphogenesis of the skull, eyes, sensory organs,
and cranial ganglia (Schorle et al., 1996; Zhang et al., 1996).
Two additional AP2-related genes were later character-
ized, AP2b and AP2g (Moser et al., 1995; Oulad-Abdelghani
et al., 1996). The basic DNA-binding domain which over-
laps with a helix–span–helix (HSH) dimerization domain is
highly conserved in the three members of the AP2 family
(Williams and Tjian, 1991a,b; Moser et al., 1995; Oulad-
Abdelghani et al., 1996). Therefore, AP2, which encodes
four mRNA variants produced by alternative splicing in the
embryonic mouse (Meier et al., 1995), was later renamed
AP2a. The four mRNA variants share the DNA binding/
dimerization domain. Variants 3 and 4 differ from variants
1 and 2 in their exon 1, due to the usage of different
promoters. Variant 2 differs from variant 1 in the absence of
exon 2, which encodes the transactivation domain, as a
result of alternative splicing.
The precise spatial and temporal regulation of gene ex-
pression in the ocular lens provides a useful model for
studying transcriptional regulation during development.
We have been studying the transcriptional regulation of the
MIP gene which is specifically expressed in the lens fiber
cells. Purified human AP2a interacts with a domain of the
human MIP gene required for promoter activity in lens cells
(Ohtaka-Maruyama et al., 1998). The eye phenotype of the
AP2a null mice is similar to the mutant phenotype of Pax6,
which was identified as a master control gene for eye
development (Halder et al., 1995; Morris-Kay, 1996; Schorle
et al., 1996; Zhang et al., 1996), suggesting that AP2a may
also play an important role in ocular development. To
examine the role of AP2a in lens differentiation and in the
regulation of lens-specific gene expression, we studied the
spatial localization of AP2a in the lens and the expression
of each of the four AP2a isoforms in the lens. We found
expression of the AP2a gene in the lens epithelia but not in
the lens fibers. Our results show that three of the four
isoforms which had been reported and one novel AP2a
isoform which lacks part of the proline-rich transactivation
domain are expressed in the lens. The ratio of negative and
positive regulatory AP2a isoforms may play a role in the
precise regulation of gene expression in the lens.
MATERIALS AND METHODS
Oligonucleotides. Oligonucleotides were synthesized either in
an Applied Biosystems synthesizer or in a Perspective Biosystems
Expedite nucleic acid synthesis system followed by purification in
G-25 Sephadex columns.
RT-PCR analysis of AP2 transcripts in various tissues. Total
RNA was isolated from various tissues of 5-day-old mice by the
guanidinium thiocyanate/phenol chloroform single-step extraction
method. Poly(A) RNA was isolated with oligo(dT)-Dynabeads (Dy-
nal As, Oslo, Norway). One microgram of poly(A) RNA was
reversed transcribed using the first-strand synthesis kit (Clontech)
with random primers. Five microliters of first-strand reaction was
amplified by PCR using amplimers corresponding to AP2a cDNA
sequences (Meier et al., 1995), as indicated in Fig. 1. The oligonu-
cleotide sequence for primers A through H, indicated in Fig. 1 are:
A, 59-ACTTTGCGCTAACCCAGAGA-39, and B, 59-GAGGGGC-
AAATCCGATCACG-39 (exon 1a, sense primer); C, 59-CTGGGA-
GGATAGAGATCGTG-39, and D, 59-GTTACCCCAGACTCTTC-
GCA-39 (exon 1b, sense primer); E, 59-GCCTGCTTCACTTCTTG-
GGT-39,and F, 59-GTTGATACCCCCTACTTCGG-39 (exon 1c,
sense primer); G, 59-CGTGAGGAGAGTAACGTTG-39,and H, 59-
CCCTGCTGGCAGATTCA-39 (exon 5, antisense primer); I, 59-
ATCTGCCAGCAGGGAGACGTAAAGCTGCCA-39 (exon 5,
sense primer); and J, 59-GGCCT CGGTGAGATAGTTCTGCA-
GGGCCGT-39 (exon 7, antisense primer).
As a positive control, an equal amount of first-strand reaction
was amplified with primers corresponding to G3PDH, 0.45-kb
control amplimer set (Clontech). The PCR conditions were 30
cycles at 94°C, 1 min for denaturation; 60°C, 1 min for hybridiza-
tion; and 72°C, 2 min for extension. The PCR products were
analyzed by polyacrylamide gel electrophoresis.
To specifically amplify transcripts from the AP2b gene, the fol-
lowing oligonucleotides were designed and synthesized: 59-CACA-
CGCCATCATCGGACTT-39 (exon 2, sense) and 59-GGGAGGG-
ACAGGAACTTTTT-39 (exon 3, antisense), at positions 355/374
and 776/795, respectively (Moser et al., 1995). To specifically
amplify transcripts from the AP2g gene the oligonucleotides 59-
CCTGGATTTAACTGGCGACT-39 (noncoding exon 1, sense) and
59-CCTCCAGCCCTGAAATATGG-39 (exon 2, antisense), at posi-
tions 180/199 and 599/618, respectively (Oulad-Abdelghani et al.,
1996) were designed and synthesized. The RT-PCR conditions were
similar to the ones for AP2a, except that the hybridization step was
at 63°C.
PCR products were analyzed in 6% polyacrylamide electro-
phoresis.
Cloning and sequencing of RT-PCR products. The RT-PCR
products obtained with each amplimer were cloned into the
pCR-Script Amp SK(1) vector, using the PCR-Script cloning kit
(Stratagene). Five microliters of each PCR reaction mixture was
ligated to the SfI-linearized vector with T4 DNA ligase at room
temperature for 1 h and transformed into Escherichia coli strain
XL1-blue. Plasmids were isolated from positive white colonies.
Both strands of each inserted DNA fragment were sequenced using
the dideoxy method with fluorescein-labeled single primers in the
ALF express automated sequencing system (Pharmacia).
In situ RT-PCR. Heads isolated from embryonic day 14 mice
were fixed in 4% paraformaldehyde and paraffin embedded and eye
sections containing the lens in the anterior/posterior orientation
were obtained. Pretreatment of the sections was as follows: depar-
affination with xylene (twice, 10 min each); ethanol series (twice
100, 95, 75, 50, and 30%), 1 min each; PBS for 2 min; 4% PFA/PBS
for 20 min; 20 mg/ml proteinase K in 50 mM Tris–HCl, pH 8.0,
5mM EDTA for 7.5 min; PBS for 2 min; 4% PFA/PBS for 5 min; PBS
for 2 min; water quick dip; 0.1 M TEA–0.4% acetic anhydride for
10 min; PBS for 2 min; EtOH series (30, 50, 75, 95, and 100%); and
air drying for 30 min. For the reverse transcription (RT) reactions,
65 ml of water and 5 ml of oligo(dT) primer (0.5 mg/ml) were added to
the tissue sections and covered with Parafilm. Slides were incu-
bated at 70°C for 10 min followed by cooling on ice for 1 min. Slides
were incubated with SuperScript II reverse transcriptase (Gibco-
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BRL) as indicated by the manufacturer. After the RT reaction,
slides were rinsed twice with PBS. The sections were covered with
the PCR reaction mixture and sealed with a SlideSeal (Hybaid,
England). The PCR reaction mixture contained primers I and J, 1 ng
each, in a 100-ml PCR reaction mixture containing digoxigenin-
dUTP, Taq polymerase, and Taq Start antibody from the Expand
high-amplification system kit (Boehringer Mannheim). PCR reac-
tions were performed in a OmniSlide thermal cycler (Hybaid);
amplification conditions were 20 cycles at 94°C for 15 s, 55°C for
15 s, and 72°C for 1 min and one cycle of 72°C for 5 min. Negative
controls either without the addition of RT or without amplimers
were performed at the same time. After the PCR reaction, the slides
were washed with 0.13 SSC at 45°C for 20 min and rinsed in DIG
system buffer 1 (Boehringer Mannheim) at room temperature for 10
min. The color reaction with antidigoxigenin and NBT-BCIP was
performed according to the nonradioactive DIG detection kit from
Boehringer Mannheim. The slides were then mounted with Crys-
talmount and Permount (Fischer).
RESULTS
The AP2 Gene Is Expressed in the Lens
Poly(A) RNA was isolated from the ocular lens and eight
additional tissues were dissected from 5-day-old mice. In
order to examine the expression of the AP2a gene in the
lens, we performed RT-PCR analysis with primers I and J,
corresponding to exons 5 and 7, respectively (Fig. 1). This
amplimer amplifies a region present in the four AP2a mRNA
variants which encodes the DNA-binding/dimerization do-
main. As shown in Fig. 2, an expected band of approxi-
mately 392 bp was detected in the lens, kidney, and
cerebellum. Weak bands were detected in brain, thymus,
lung, and heart, but no bands were observed in liver and
spleen. These data indicate that the AP2a gene is expressed
in the ocular lens.
Spatial Localization of AP2a mRNA in the Lens
To determine the localization of AP2a expression in the
lens, we analyzed the spatial localization of AP2a mRNA in
paraffin embedded eye sections from E14 mouse embryos.
We initially performed in situ hybridization with the
digoxigenin-labeled AP2a antisense riboprobe from plasmid
pB240 (Mitchell et al., 1991), but no positive signal was
detected. Therefore, we performed in situ PCR using the I/J
amplimers which amplify exon 5 to exon 7 (Fig. 1). We
detected a strong signal in lens epithelial cells but not in the
fiber cells of 14-day-old mouse embryo (Fig. 3A). Two
negative controls were performed, one without the incuba-
tion step with reverse transcriptase and another one with-
out the addition of PCR primers to the PCR reaction (Fig.
3B). No NBT-BCIP hybridization signal was observed in the
absence of RT or primers. These results show that the gene
encoding the transcription factor AP2a is expressed in the
whole anterior lens epithelia region and stops being ex-
pressed as soon as the epithelial cells start elongating in the
equatorial region.
FIG. 1. Diagram of AP2a variants. Exon 1 to 3 boundaries in variants 1 to 4 are based on Meier et al., 1995; exon 5 to 7 boundaries are
based on the human AP2a gene (Bauer et al., 1994). (1) indicates initiation of exon 1; line indicates exon 1 untranslated sequence; dotted
bar, coding exon 1a (E1a); hatched bar, coding exon 1b (E1b); solid bar, coding exon 1c (E1c). Arrows indicate the location and orientation
of primers designed for RT-PCR experiments. Exons 2 to 7 are indicated as E2–E7, respectively. The location of the activation, DNA-binding
and dimerization domains is indicated with brackets (Williams and Tjian, 1991a,b; Bauer et al., 1994).
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AP2a mRNA Variants Expressed in the Lens
Meier et al. (1995) characterized four mRNA variants
derived from the AP2a gene in embryonic mice. Variants 1,
3, and 4 arise from the usage of three different promoters;
variants 1 and 2 are transcribed from the same promoter but
variant 2 lacks the activation domain encoded in exon 2 due
to alternative splicing (see Fig. 1). As the amplimers used in
the previous experiment (Fig. 2) amplify the four isoforms,
additional experiments are required to determine which
isoforms are expressed in the lens. To address this question,
we performed RT-PCR using variant-specific primers. Fig-
ure 4 shows the results obtained with the lens and eight
additional tissues. Variants 1 and 2 were analyzed using the
primers A and G, corresponding to exon 1a and 5, respec-
tively (see Fig. 1) and the results obtained are shown in Fig.
4A. When we used the amplimer A/G, a 949-bp band
derived from variant 1 was detected in the lens, kidney, and
cerebellum; faint bands were also detected in brain and
lung. As exon 2 is deleted in variant 2, a 514-bp RT-PCR
product would be expected from this variant. As shown in
Fig. 4A, the band corresponding to variant 2 was also
detected in the lens, kidney, and cerebellum. We consis-
tently noticed an additional band migrating with a mobility
between the amplified products of variants 1 and 2; this
band was detected in the lens and kidney but not in other
tissues. To confirm this result we designed two additional
primers for exons 1a and 5, primers B and H respectively
(see Fig. 1). The additional band was also detected with the
amplimer B/H (see Fig. 5B).
To detect variant 3, we designed two primers specific to
exon 1b. Figure 4B shows the results obtained with the
amplimer C/G. The expected 1.1-kb band derived from
variant 3 was observed in kidney and cerebellum. A weaker
band was detected in the lens, brain, and lung (Fig. 4B). A
band with the expected size for variant 3 was also detected
in the lens using another amplimer for exons 1b and 5
(primers D/H, Fig. 1) (data not shown).
To detect variant 4, we used primers E and G, correspond-
ing to exons 1c and 5, respectively. As shown in Fig. 4C, the
corresponding band of 987 bp was detected only in the
cerebellum but not in other analyzed tissues. This result
was reproducible when we used the amplimer F/H (data not
shown).
Variant 5 Is a Novel AP2a mRNA Variant
Produced by Alternative Splicing
To verify that the RT-PCR products obtained with lens
RNA correspond to the predicted AP2a mRNA variants, the
PCR products were cloned and sequenced. Cloning and
sequencing of the RT-PCR products obtained with am-
plimers A/G (949- and 514-bp bands) and C/G (1148-bp
band), corresponding to variants 1, 2, and 3, respectively,
were 100% identical to the sequences that had been re-
ported by Meier et al. (1995). Sequencing of the 784-bp band
obtained with lens RNA using amplimer A/G revealed the
presence of a novel AP2 mRNA variant containing a 165-bp
deletion in exon 2 (Fig. 6). We named this new isoform
variant 5. Our data show that the lens expresses AP2a
variants 1, 2, 3, and 5; variant 4 is not expressed in the lens
(Figs. 5A and 5B). Variants 1, 2, and 3 are also expressed in
the kidney and cerebellum (weak expression was observed
in brain and lung). Variant 4 is expressed only in the
cerebellum. Besides being expressed in the lens, variant 5 is
also expressed in the kidney. Our data also confirmed
previous observations by others (Mitchell et al., 1991;
Meier et al., 1995; Moser et al., 1995, 1997b) that the AP2a
gene is expressed in some selected tissues; no AP2a variant
was observed in thymus, spleen, heart, and liver (see Fig. 4).
Nucleotide sequence analysis of the 165-bp deleted in
variant 5 indicates the presence of splicing signals in this
DNA fragment. The sequences GT and AG, which are
present at the 59- and 39-end, respectively, of this DNA
fragment, are highly conserved in the 59- and 39-ends of
introns (Balvay et al., 1993). Furthermore, the sequences
flanking the 59- and 39-ends of this deletion show similari-
ties to the 59-splice site AG/GT [A/G]AGT and 39 splice site
CAG/G consensus sequence, respectively. In the deleted
FIG. 2. Analysis of AP2a gene expression in various mouse
tissues by RT-PCR. Poly(A) RNA was isolated from various mouse
tissues and analyzed by RT-PCR as indicated under Materials and
Methods. (Top) Polyacrylamide gel electrophoresis using the am-
plimers I/J (exons 5 and 7, respectively (see Fig. 1). (Bottom)
Polyacrylamide gel electrophoresis using amplimers corresponding
to G3PDH. Lane 1, DNA size markers (fX174 HaeIII digested
fragments); lane 2, lens RNA; lane 3, kidney RNA; lane 4, brain
(cerebrum) RNA; lane 5, thymus RNA; lane 6, cerebellum RNA;
lane 7, lung RNA; lane 8, liver RNA; lane 9, heart RNA; lane 10,
spleen RNA. Arrows indicate the expected amplified band with the
AP2a I/J amplimers, 392bp (top), and with G3PDH amplimers,
452bp (bottom).
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sequence there is an adenine positioned 18 nucleotides
from the 39-junction, followed by a pyrimidine-enriched
region (Figs. 6 and 7B). This adenine correlates well with the
branch point, which is the site of lariat formation, generally
found 15 to 40 nucleotides upstream of the 39-splice site,
followed by a stretch of pyrimidines. Thus, the 165-bp
deleted in AP2a variant 5 contains the conserved consensus
splicing signals characteristic of an intron. Therefore, the
165-bp deletion in variant 5 may be considered an intron,
intron 2ab, spliced out by alternative splicing, generating
the novel exons 2a and 2b (see Figs. 7A and 7B). The stretch
of pyrimidines between the lariat and the 39-splice site in
intron 2ab contains some purine insertions, the 39-end of
exon 2a and the 59-end of exon 2b differ from the consensus
59- and 39-splice signals. As these features probably result in
a weaker signal for splicing intron 2ab, retention of this
intron to form exon E2 may be the preferred alternative
splicing event.
FIG. 3. Localization of AP2a transcripts in the lens by in situ PCR. Paraffin head sections of 14-day-old mouse embryo were deparaffinized
and fixed as indicated under Materials and Methods. The RT reaction, in situ PCR reaction and color development were performed as
described under Materials and Methods. (A) In situ PCR was performed with amplimers I/J. (B) Negative control without the addition of
amplimers I/J to the PCR reaction (similar results were obtained without the incubation with reverse transcriptase in the RT step). f, lens
fibers; arrow indicates lens epithelia; r, retina. Magnification, 1003.
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The 165-bp in-frame-deletion in variant 5 encodes a
proline-rich region 55 amino acids long, part of the AP2a
transactivation domain (Fig. 7C) (Williams and Tjian,
1991b). Therefore, variant 5 may function as a repressor.
The AP2b and AP2g Genes Are Not Expressed in
the Lens
Two other members of the AP2 family, AP2b and AP2g,
with an expression pattern different from AP2a, have been
isolated (Moser et al., 1995, 1997b; Oulad-Abdelghani et al.,
1996). The DNA-binding domain is highly conserved in the
three members of the AP2 family but the dimerization and
activation domains are less conserved (Oulad-Abdelghani et
al., 1996). When we aligned the amino acid sequence
encoded by exon 2, we found that the 55 amino acid domain
deleted in AP2a variant 5 was highly conserved in the three
members of the family (see Fig. 8). Therefore, it was
important to determine whether the AP2b and AP2g genes
are also expressed in the lens to contribute to the regulation
of gene expression in this tissue. To this end, we performed
RT-PCR with primers specific for each gene. AP2b was
expressed in the kidney, brain, and cerebellum. APg was
expressed in the brain, cerebellum, and lung as shown by
others (Moser et al., 1995, 1997b; Oulad-Abdelghani et al.,
1996). However, neither AP2b nor AP2g was expressed in
the lens (Fig. 9).
DISCUSSION
AP2a Gene Expression in the Lens
We report in this study the finding of a novel splicing
variant of the AP2a gene in the lens which shows tissue
selectivity and which may have implications in regulating
gene expression in the lens.
The ocular lens develops from the surface ectoderm by
induction of the optic pit in the region of the future
forebrain during embryogenesis. After the lens vesicle de-
taches from the surface ectoderm, epithelial cells in the
equatorial zone start differentiating into primary fibers
filling the whole lens vesicle. Several lens-specific genes,
including crystallins and MIP, start being expressed at this
differentiation stage. Transcription factors that interact
with promoter elements of several crystallin genes have
been characterized, dEF-1 (Funahashi et al., 1993), Sox-2
(Kamachi et al., 1995), several zinc finger proteins (Liu et
FIG. 5. RT-PCR analysis of AP2a variants expressed in lens. Poly-
acrylamide gel electrophoresis of PCR products. (A) Lane 1, DNA size
marker (fX174 HaeIII digestion fragments). Lens RNA RT-PCR with
amplimers A/G (lane 2), C/G (lane 3), and E/G (lane 4). Arrows to the
left indicate the PCR products of expected size for variants 1, 5, 2, and
3 with amplimers A/G; arrow to the left indicates variant 3 expected
size with amplimer C/G. (B). Lane 1, DNA size marker (fX174 HaeIII
digestion fragments). Lens RNA RT-PCR with primers A/G (lane 2)
and B/H (lane 3). Arrows to the right indicate variants 1, 5, and 2
expected length with amplimer B/H.
FIG. 4. AP2a isoforms analysis in various tissues by RT-PCR.
Polyacrylamide gel electrophoresis of RT-PCR products using
poly(A) RNA isolated from various tissues, performed with AP2a
variant specific primers. (A) Amplimer A/G (exons 1a and 5); (B)
amplimer C/G (exons 1b and 5); (C) amplimer E/G (exons 1c and 5);
(D) G3PDH amplimers. Size markers are indicated to the left. Sizes
of the expected RT-PCR products for each variant are indicated
with an arrow to the right.
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al., 1994; Brady et al., 1995), members of the Maf gene
family (Ogino and Yasuda, 1998; Sharon-Friling et al., 1998)
and Pax6 (Cvekl et al., 1995a,b; Richardson et al., 1995;
Sharon-Friling et al., 1998). However, these factors are not
lens specific, being also expressed in other tissues. This
suggests that interaction of non-lens-specific transcription
factors may be important for determining lens-specific gene
expression.
We found that the AP2a gene, which is preferentially
expressed in some tissues (Mitchell et al., 1991; Meier et
al., 1995; Moser et al., 1995, 1997b), is also expressed in
the lens and retina. In the lens, AP2a gene expression
localizes to the central and equatorial lens epithelia but
not to the lens fibers. AP2a pattern of expression in the
lens is similar to the one displayed by Pax6 (Richardson
et al., 1995). Pax6 is a paired- and homeodomain-
containing protein which is considered to be a master
control gene for eye development (Halder et al., 1995).
The eyes of AP2a-null embryos resemble those of Pax6
mutant embryos in the deep-set optic cups and absence of
lenses (Grindley et al., 1995; Schorle et al., 1996; Zhang
et al., 1996). However, a lens rudiment was occasionally
observed in the AP2a-null embryos, suggesting that tem-
porary inductive contact between the optic epithelium
and lens ectoderm had been made (Schorle et al., 1996;
Morris-Kay, 1996). Therefore, AP2a may also be involved
in regulating early lens differentiation.
AP2a Variants Expressed in the Lens
We found that the transcripts of the AP2a gene in the lens
code for two activator forms (variants 1 and 3) and two
potential repressor forms (variants 2 and 5). The promoters
for variant 1 and 3 are functional in the lens; however, the
promoter for variant 4 is not active in the lens and appears
to have a more restricted tissue specificity. The whole exon
2 is deleted in variant 2, whereas the transactivation do-
main is only partially deleted in variant 5. Whether the two
different repressor forms are expressed in the same or
different lens epithelia cells remains to be elucidated. It is
possible that exons 2a and 2b, which contains regions of the
transactivation domain may be responsible for interaction
with other proteins, different from the ones which interact
with variant 2 or variant 3. As a result, variant 5 may
regulate target genes differently from variant 2. Different
amino acids in the N-terminal region of the transactivation
domain of variants 1 and 3 may also modulate the activator
activity of these two isoforms.
The Novel AP2a Variant Is Produced by
Alternative Splicing
The novel AP2a variant 5 has a 165-bp in-frame deletion
within exon 2 which corresponds to a 55 amino acid
deletion in the proline-rich transactivation domain. The
presence of splicing signals inside this deletion suggests it is
an intron spliced out by alternative splicing. mRNA splic-
ing usually involves excision of intron sequences and liga-
tion of the exon sequences. Alternative splicing usually
involves skipping exons; however, partial splicing of exons
has also been observed in several genes, such as the human
caldesmon, the bovine growth hormone, and Pax6 genes
(Humphrey et al., 1995; Dirksen et al., 1995; Richardson et
al., 1995; Jaworski et al., 1997). Splicing signals inside
exons have been characterized in several genes (Conboy et
FIG. 6. Nucleotide sequence of AP2a variant 5. Alignment of
mouse AP2a variant 1 and variant 5 DNA sequences. Bold arrows
indicate the location of primers A and G. Position number 1
corresponds to bp number 23 in AP2a variant 1. Identical se-
quences are shown in shaded boxes. 59-end of exons 2 to 5 are
indicated with arrows. (—) Nucleotides deleted in variant 5, corre-
sponding to variant 1 nucleotides 178/343 . Splicing signal se-
quences are underlined. (*)Adenine at the putative branch site of
the splicing signal.
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al., 1991; Humphrey et al., 1995; Kornblihtt et al., 1996).
Tissue- and development-specific RNA splicing results in
multiple heterogeneity of the erythroid membrane protein
4.1 (Conboy et al., 1991). Secondary splicing from pre-
mRNA is also proposed as a mechanism to create in-frame
internal deletions in the transcription factor LSF (Shirra et
al., 1994). In these cases, a tissue- or development-specific
splicing factor could bind with different affinity to each
splice site. Exon-splicing enhancer sequences (ESE) located
in downstream exons have been characterized in immuno-
globulin, growth hormone, and fibronectin primary tran-
scripts to facilitate splicing of weak splicing signals (Watak-
abe et al., 1993; Dirksen et al., 1995; Kornblihtt, 1996).
Their interaction with trans-acting factors may facilitate
the splicing process. Additional splicing factor(s) may be
required when weak splicing signals are present (Watakabe
et al., 1993; Berget, 1995; Kornblihtt et al., 1996). As
splicing signals in AP2a intron 2ab shows some deviations
from the consensus sequences, it could be considered a
weak splicing site. Therefore, ESE may be present in exon
E2b or intron 2. As we have observed splicing of intron 2ab
in AP2a variant 5 in lens and kidney but not in other
tissues, it may very well be that this factor(s) may be
selectively expressed in these two tissues. Similarities in
gene regulation in lens and kidney have been observed;
BMP7 null mutant mice show developmental defects in
kidney and lens (Dudley et al., 1995; Luo et al., 1995; Jena
et al., 1997). Therefore, the presence of this AP2a splice
variant in lens and kidney may be due to the presence of the
factor(s) required for this splicing event in these two tissues.
FIG. 7. Variant 5 is produced by alternative splicing. (A) Diagram showing alignment of exons 1 to 3 in variants 1 and 5. 59- and 39-end
exon sequences are indicated. Sequence at 39- and 59-end of the 165-bp deletion in variant 5 exon 2 may be considered a new intron (2ab),
which is spliced out in variant 5, creating exons 2a and 2b. Exons are indicated as shaded boxes; introns are indicated with broken lines.
(B) Diagram indicate the splicing signals present in intron 2ab, that may be responsible for this alternative splicing event. (C) Comparison
of deduced amino acid sequence encoded by AP2a exon 2 between variant 1 and variant 5. Conserved amino acids are shown in shaded
boxes. (—) The deleted region in variant 5. Shaded box at the N-terminal side of the deletion corresponds to exon 2a and at the C-terminal
side of the deletion corresponds to exon 2b. (P) Prolines and (Q) glutamines present in exon 2 . Numbers refer to the amino acid sequence
of AP2a variant 1 (Meier et al., 1995).
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Possible Role of AP2a in Transcriptional
Regulation in the Lens
The AP2 family of transcription factors may play a role in
regulating apoptosis. AP2a knockout mice show apoptosis
of midbrain (Schorle et al., 1996; Zhang et al., 1996) and
AP2a may play a role in remodeling of limb buds during
chicken embryonic development (Shen et al., 1997). AP2b
knockout mice show apoptotic cell death of collecting duct
and distal tubular epithelia. AP2a and AP2b repress apopto-
sis induced by c-myc, suggesting that they may play a role
in programming cell survival during embryogenesis (Moser
et al., 1997a). As loss of cell nuclei during lens fiber
differentiation has some characteristics of apoptosis (Bass-
nett and Mataic, 1997; Zelenka et al., 1997), the absence of
AP2a gene expression in the lens fibers may play a role in
activation of the denucleation process in the lens fibers.
We observed AP2a expression in the lens equatorial
region, where lens epithelia cells withdraw from the cell
cycle and start differentiating. AP2a has been shown to
inhibit cell cycle progression and activation of an AP2-
responsive promoter element of the p21 gene, which en-
codes a cdk inhibitor, in cancer cells (Zeng et al., 1997).
Therefore, AP2a activator variant/s may play a role in
withdrawal from the cell cycle by activating transcription
of p21 or other cell cycle regulators in the lens (Fromm and
Overbeek, 1997; Zelenka et al., 1997).
Putative AP2-binding sites are present in the promoter
region of several lens-specific crystallin genes (Piatigorsky
and Zelenka, 1992). Therefore, AP2a activator variants may
activate expression of genes expressed in lens epithelia
whereas repressor variants may repress expression in epi-
thelia of genes specifically expressed in the lens fibers (i.e.,
g-crystallins and MIP).
We previously characterized a promoter element of the
human MIP gene containing overlapping binding sites for
FIG. 8. Exon 2 amino acid sequence encoded by AP2a, AP2b, and AP2g mouse genes. Conserved amino acids are shown in shaded boxes.
Bracket shows amino acids deleted in AP2a variant 5. D55 a.a., 55 amino acid deletion in AP2a variant 5. Alignment of mouse AP2a amino
acids 16 to 160 (Moser et al., 1993), AP2b amino acids 17 to 169 (Moser et al.,1995), and AP2g amino acids 17 to 177 (Oulad-Abdelghani
et al., 1996).
FIG. 9. Analysis of AP2b and AP2g gene expression in various
mouse tissues. Poly(A) RNA isolated from various mouse tissues
were used for RT-PCR with specific primers of AP2b, AP2g, and
G3PDH as indicated under Materials and Methods. Polyacrylamide
gel electrophoresis of PCR products of AP2b (top), AP2g (middle),
and G3PDH as a positive control (bottom). Lane 1, DNA size
markers; lanes 2 to 10, RT-PCR with RNA from tissues indicated
above the top panel. Arrows to the right indicate the expected size
for the RT-PCR product with each amplimer.
133Transcription Factor AP2a Expression in Murine Lens
Copyright © 1998 by Academic Press. All rights of reproduction in any form reserved.
the transcription factors Sp1 and AP2a (Ohtaka-Maruyama
et al., 1998). This regulatory element is conserved in the
human and mouse MIP gene (Ohtaka-Maruyama and Che-
pelinsky, unpublished). As the MIP gene is specifically
expressed in the lens fibers, AP2a variants 2 and 5 may
function as repressors of MIP expression in lens epithelia.
However, as we found AP2a expression in the lens equato-
rial region where lens cells begin differentiating, AP2a
variants 1 and 3 may be involved in activating MIP tran-
scription, if expressed in those cells. Therefore, it will be
important to determine which activator and repressor AP2a
variants are expressed in the central lens epithelia and in
the equatorial region and whether activator and repressor
AP2a variants are coexpressed in the same cell or in differ-
ent lens cells.
Further studies will allow us to elucidate whether AP2a
variant 5 functions as a repressor by interacting with the
AP2-binding regulatory element, through its DNA-binding
domain, but unable to interact with coactivators or as a
modulator by having a different protein–protein interaction
domain or different affinity with coactivator/s.
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